Enhanced Purple Book patent and exclusivity information!

Drug Patent Expirations, Patent Titles, Claim Types,
Hyperlinks to the Patents and much more!

Contact:

Orange Book Companion® Current Working Samples Tradenames-A Generic Names-A Companies-A Drug Classes-A Part 1 Products whose next patent expiration is in: 2024 2025 Subscribers see all the years - currently through 2040	Click a link, below, to enter the Purple Book Companion™ Online What's New (July 2023) Indexes by Trademark   Generic Name   Company All Patents Free "Beta" Trial - No registration needed Updated through  July 2023 Please let me have your comments and suggestions!	Orange Book Companion® Purchase a new subscription, or renew your current subscription, to the Orange Book Companion® for only $295/year New subscribers receive a 30-day money back guarantee! Not a subscriber? Learn more about the Orange Book Companion® Please read our very reasonable subscription Terms and Conditions.
Orange Book Companion® News Our Orange Book Archive™ (included  at no additional cost to subscribers) has now been updated through Dec. 31, 2023. Bruce Pokras' Conference Presentation List Press Release Archive Pharmaceutical News Links	Enter Orange Book Companion® Online (Vol. 44, Supp. 10) Subscribers, only! Orange Book  Companion® "What's New" (Vol. 44, Supp. 10) No subscription needed! A New Orange Book Patent Listing Champion! AUVELITY stands alone with 120 patents listed in the Orange Book. Blowing away VAXCEPA's previous record of 68 patents! Blazing Dawn Software Economical software for Mac and Windows. Search for and download US, EP, PCT and many international patents and published applications with Patent GrabberTM. Explore many of Patent Grabber's additional features in its free trial mode. Still need to write checks? Try out ChecksQuick™.	Orange Book Insights™ Blog July 25, 2023: Make sure that your patent exists before submitting a 3542 form for the patent to the FDA Aug. 13, 2022: Orange Book Vol. 42/Supp. 6 News: Watch Out for the Breadth of Your Use Codes June 23, 2022: Orange Book Vol. 42/Supp. 5 News Mar. 15, 2022: Learn about a new Orange Book Companion® feature. Feb. 18, 2022: Purple Book Companion™ (beta) Announcement Jan. 29, 2022: When are eight 0.5g capsules not equivalent to four 1g capsules? Jan. 13, 2022: "What's New" Giveaway Announcement Sept. 29, 2021: Mystery: is there a difference between ASTEPRO ALLERGY and Children's ASTEPRO ALLERGY? May 7, 2021: Interesting New Patents From FDA's Orange Book: Vol. 41, Supplement 3. Jan. 29, 2021: Dreams Do Come True: The Purple Book is getting patent listings! Dec. 22, 2020: Parts is Parts? A few thoughts about some of the comments that were submitted to the FDA about Orange Book listings. Aug. 2, 2020: Speculation about the delisting of a "part" patent from the Orange Book
Melron Records Melron's "King Love" by the Allures was used in Season 2, Episode 5 of Netflix's "Master of None" starring Aziz Ansari. In that episode, Ansari's character, Dev Shah, is at a bar with a date. As he and his date are talking, "King Love" is playing softly in the background. Download song samples and full length MP3's of Melron's "Philly Sound" music from the late 50's and early 60's. Then purchase the CD or download or stream your favorites from Apple iTunes or the Apple Music service	Orange Book Companion® Two-Volume Book Set To be revived! Please let me know if you would be interested by sending an email to the contact address at the bottom of this page.  In the meantime, read all about it. Photos, Description and Samples

 
Links are provided to the web pages of other organizations who are not associated with Blazing Dawn Software. NDA Numbers are linked to a page of the U.S. Food and Drug Administration's "Electronic Orange Book." Patent Numbers are linked to a page provided by the U.S. Patent and Trademark Office. Full text and abridged images of patents that are provided under a Flash Drive subscription were obtained from the U.S. Patent and Trademark Office.

All trademarks in the Patent & Exclusivity Information and in the Reference Listed Drug information are the property of the various drug companies who market the products, or their licensors.

Latest Update: November 14, 2024
© 2001-2024 Bruce A. Pokras, All rights reserved worldwide
Contact: